SCHEDULE: Artisan Partners Discloses 5.2% Stake in Ascendis Pharma

Artisan Partners Asset Management Inc. and its affiliates reported a 5.2% beneficial ownership stake in Ascendis Pharma A/S American Depositary Shares as of December 31, 2025.

Summary

• Artisan Partners Asset Management Inc. and its affiliates (Artisan Partners Holdings LP, Artisan Investments GP LLC, and Artisan Partners Limited Partnership) collectively beneficially own 3,225,885 American Depositary Shares of Ascendis Pharma A/S.
• This represents 5.2% of Ascendis Pharma A/S's outstanding shares, based on 61,977,408 shares outstanding as of December 30, 2025.
• The reporting persons have shared voting power over 2,883,433 shares and shared dispositive power over 3,225,885 shares.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Ascendis Pharma A/S.
• The ownership is on behalf of discretionary clients of Artisan Partners Limited Partnership, with no single client holding more than 5% economic interest.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a significant institutional investor maintaining or establishing a 5.2% stake suggests continued confidence in Ascendis Pharma A/S, without any indication of an activist agenda.

Positives

• A significant institutional investor, Artisan Partners, holds a 5.2% stake, indicating confidence in Ascendis Pharma A/S.
• The investment is for ordinary course of business, not for activist purposes, suggesting a long-term, passive investment approach.

Negatives

• The filing is an amendment (No. 6), but without prior filings, it is impossible to determine if the stake has increased or decreased, which could be a positive or negative signal.

Future Outlook

No forward-looking statements or guidance from Ascendis Pharma A/S are provided in this filing.

Industry Context

StockSavvy.ai notes that institutional filings like this Schedule 13G provide transparency into significant ownership stakes, which can signal institutional confidence in a company's long-term prospects within the biotechnology and pharmaceutical sectors. Artisan Partners is a well-known asset manager, and their continued or established stake suggests a belief in Ascendis Pharma's value proposition.

Comparison to Industry Standards

• Institutional ownership of 5.2% by a major asset manager like Artisan Partners is a common occurrence for publicly traded biotechnology companies.
• This level of ownership is typical for a passive investment by a large fund, rather than an activist stake, which often involves higher percentages and more explicit intentions to influence management.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake can provide a level of reassurance and potentially influence investor sentiment positively.
• Management: Indicates that a major institutional investor is monitoring the company, but without an activist intent.

Key Dates

Recommendation

The filing indicates a stable institutional ownership stake by Artisan Partners, suggesting a continued passive investment. It does not provide new information regarding Ascendis Pharma's operational performance, strategic direction, or financial health that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate for existing investors, while new investors would need to conduct further due diligence beyond this ownership disclosure.

Keywords

Ascendis Pharma, Artisan Partners, Schedule 13G, Institutional Ownership, ADS, Biotechnology, Pharmaceuticals, Investment Management, Shareholding Disclosure